Recombinant Human Bax Protein，His

Bax, a pro-apoptotic protein belonging to the Bcl-2 family, plays a crucial role in the intrinsic pathway of programmed cell death. It is known for its ability to permeabilize the mitochondrial membrane, leading to the release of cytochrome c and subsequent activation of caspases, which are essential for executing apoptosis. Research on Bax has gained momentum due to its implications in various diseases, including cancer, where its expression levels often correlate with the cell's response to chemotherapeutic agents. Understanding Bax’s structure and function provides insights into its regulatory mechanisms and potential as a therapeutic target. Recombinant Bax protein studies have facilitated the exploration of its interaction with other mitochondrial proteins and the elucidation of its apoptotic mechanisms at the molecular level. These studies aim to define how Bax and its homologs contribute to the balance of cell survival and death, which is pivotal in therapeutic contexts, especially in cancer treatment strategies aiming to restore apoptotic pathways in resistant cells. Thus, the investigation of recombinant Bax not only enhances comprehension of the apoptotic process but also fosters the development of novel approaches to modulate apoptosis in various diseases, thereby illuminating new potential for targeted cancer therapies.